Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes